189 related articles for article (PubMed ID: 24621930)
1. Increased microRNA-630 expression in gastric cancer is associated with poor overall survival.
Chu D; Zhao Z; Li Y; Li J; Zheng J; Wang W; Zhao Q; Ji G
PLoS One; 2014; 9(3):e90526. PubMed ID: 24621930
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-630 is a prognostic marker for patients with colorectal cancer.
Chu D; Zheng J; Li J; Li Y; Zhang J; Zhao Q; Wang W; Ji G
Tumour Biol; 2014 Oct; 35(10):9787-92. PubMed ID: 24981248
[TBL] [Abstract][Full Text] [Related]
3. miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer.
Chen G; Wan J; Wang Z; Li L; Jia H; Xing S; Chen S; Fan X; Li R
Technol Cancer Res Treat; 2020; 19():1533033820923427. PubMed ID: 32419651
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
[TBL] [Abstract][Full Text] [Related]
5. Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells.
Jin W; Han H; Liu D
Cancer Biomark; 2019; 26(2):183-191. PubMed ID: 31403943
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.
Min C; Zhang A; Qin J
Diagn Pathol; 2019 Sep; 14(1):107. PubMed ID: 31547835
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of miR-141 downregulation in gastric cancer.
Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study.
Shi H; Han J; Yue S; Zhang T; Zhu W; Zhang D
Biomed Pharmacother; 2015 Apr; 71():210-5. PubMed ID: 25960238
[TBL] [Abstract][Full Text] [Related]
10. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
Li J; Zou X
Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
[TBL] [Abstract][Full Text] [Related]
11. The expression level of miR-203 in patients with gastric cancer and its clinical significance.
Zheng Y; Liu W; Guo L; Yang X
Pathol Res Pract; 2017 Dec; 213(12):1515-1518. PubMed ID: 29033185
[TBL] [Abstract][Full Text] [Related]
12. The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis.
Li X; Yang C; Wang X; Zhang J; Zhang R; Liu R
Med Oncol; 2014 Jan; 31(1):781. PubMed ID: 24293092
[TBL] [Abstract][Full Text] [Related]
13. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients.
Zhang J; Tian ZL; Zhang WT; Cheng LM; Liu J; Cao YX; Zhang ZR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2803-2808. PubMed ID: 31002131
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis.
Wang W; Li F; Zhang Y; Tu Y; Yang Q; Gao X
Diagn Pathol; 2013 Jun; 8():102. PubMed ID: 23786758
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer.
Li Y; Liu Y; Yao J; Li R; Fan X
Diagn Pathol; 2020 Mar; 15(1):25. PubMed ID: 32192507
[TBL] [Abstract][Full Text] [Related]
17. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
Cui Z; Zheng X; Kong D
World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
[TBL] [Abstract][Full Text] [Related]
18. Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.
Liu K; Li G; Fan C; Diao Y; Wu B; Li J
J Int Med Res; 2012; 40(2):467-74. PubMed ID: 22613407
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.
Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930
[TBL] [Abstract][Full Text] [Related]
20. miR-3178 as a prognostic indicator and tumor suppressor of gastric cancer.
Wu JC; Liu ZH; Ding X; Ke RS
Ir J Med Sci; 2022 Feb; 191(1):139-145. PubMed ID: 33547612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]